top of page

Synthetic biology firm Antheia collects $73m Series B

Menlo Park, California-based Antheia, a synthetic biology company, has raised $73 million in Series B financing. Viking Global Investors led the round with participation from other investors that included Sherpalo Ventures and Hillspire.

Read the article at Venture Capital Journal.

bottom of page